Recent Post
The lifetime management of anaphylaxis
In Australia, approximately 75% of children with allergies will experience persistent allergies, including anaphylaxis, into adulthood. Anaphylaxis is the most severe form of allergic reaction. It develops rapidly in response to allergen exposure and can be life-threatening or, in some cases, fatal. Living with the risk of anaphylaxis is often associated with a high emotional burden,…
Read MoreNew treatment for severe corneal inflammation from dry eye disease now listed on PBS
Today (Friday, 1 October, 2021), adults living with severe corneal inflammation from dry eye disease (DED) that has not improved with the use of artificial tears, will gain affordable access to a new, once-daily treatment option on the Pharmaceutical Benefits Scheme (PBS). In-licensed for the first time in Australia by Seqirus – a wholly-owned subsidiary…
Read MoreVIVA! welcomes a new team member, Lucinda!
Q: Tell us a bit about your background and what do you bring to the VIVA! team. A: I’m currently finishing up my Bachelor of Media and Communications at Macquarie University. This is my first role in healthcare PR. Before this I was a nanny and worked in retail so, I very excited at the…
Read MoreWomen’s Health Week 2021
Today (September 10) marks the final day of Women’s Health Week, an annual nationwide campaign organised by Jean Hailes. This campaign is about providing women with the information and tools to make healthier choices and check in on their own health and wellbeing. It also aims to empower women to take charge of their own…
Read MoreLack of access to COVID-19 vaccine threatening global immunity
Urgent plea to unite developing nations through vaccinations This week the Immunisation Coalition is issuing an urgent plea to Australians to help close the global COVID-19 vaccination gap by donating to UNICEF Australia in a bid to improve access in lower income countries. To date, the COVID-19 pandemic has devastatingly led to the death of…
Read More